世界の3Dプリント薬剤市場規模・予測2017-2025

◆英語タイトル:Global 3D printed drugs Market Size Study, By Drug (Spritam and Others) and Regional (US and Rest of the World) Forecasts, 2017-2025
◆商品コード:BZW80401
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2018年3月20日
◆ページ数:約110
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,150 ⇒換算¥355,950見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥627,150見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Bizwit Researchが発行した当調査レポートでは、世界の3Dプリント薬剤市場について調査・分析し、世界の3Dプリント薬剤市場規模、種類別分析、セグメント別分析、地域別分析(アメリカ市場、アジア市場、ヨーロッパ市場など)、市場動向、世界の3Dプリント薬剤関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Global 3D printed drugs industry valued approximately USD XX Million in 2016 is anticipated to grow with a healthy growth rate of XX% over the forecast period 2017-2025. 3D printed drugs are created by 3D printing technology which are used to treat patients who suffering from dysphagia. This medicine is easy to swallow and helpful for patients suffering from dysphagia. Increase in demand for fast soluble drugs which can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market. Furthermore, rising incidence of epilepsy cases, continues technological developments in 3D printing technique, and growing awareness for 3D printing technology in the developing countries are the major drivers of the market. However, concerns such as blueprint hacking and mislabeling of blueprint are going to hamper the market growth. Moreover, dicey regulatory scenario is another major restraint. In 2016, Spritam is first 3D printed drug receive approval from the FDA. It is launched by Aprecia Pharmaceuticals. This medicine is currently active only in the U.S. region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Drug:
 Spritam
 Others
Regions:
 North America
o U.S.
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the 3D printed drugs Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

Chapter 1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter 2. Global 3D printed drugs Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
Chapter 4. Global 3D printed drugs Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global 3D printed drugs Market by Drugs
5.1. Market Snapshot
5.2. 3D printed drugs Market, Sub Segment Analysis
5.2.1. Spritam
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2. Others
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 6. Global 3D printed drugs Market, Regional Analysis
6.1. 3D printed drugs Market, Regional Market Snapshot (2015-2025)
6.2. North America 3D printed drugs Market Snapshot
6.2.1. U.S. 3D printed drugs Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2. Spritam breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.3. Rest of The World 3D printed drugs Market Snapshot
6.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.3.2. Spritam breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 7. Competitive Intelligence
7.1. Company Market Share (Subject to Data Availability)
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Aprecia Pharmaceuticals
7.3.1.1. Overview
7.3.1.2. Financial (Subject to Data Availability)
7.3.1.3. Product Summary
7.3.1.4. Recent Developments
7.3.2. GlaxoSmithKline Plc.
7.3.3. Hewlett Packard Caribe
7.3.4. BV
7.3.5. FabRx Ltd
7.3.6. 3D Printer Drug Machine

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL 3D PRINTED DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL 3D PRINTED DRUGS MARKET
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION/BILLION)
TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD MILLION/BILLION)
TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD MILLION/BILLION)
TABLE 9. 3D PRINTED DRUGS MARKET BY SEGMENT 1, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 10. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 11. 3D PRINTED DRUGS MARKET BY SEGMENT 2, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 12. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 13. 3D PRINTED DRUGS MARKET BY SEGMENT 3, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 14. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 15. 3D PRINTED DRUGS MARKET BY SEGMENT 4, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 16. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 17. 3D PRINTED DRUGS MARKET BY SEGMENT 5, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 18. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 19. 3D PRINTED DRUGS MARKET BY SEGMENT 6, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 20. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 21. 3D PRINTED DRUGS MARKET BY SEGMENT 7, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 22. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 23. 3D PRINTED DRUGS MARKET BY SEGMENT 8, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 24. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 25. 3D PRINTED DRUGS MARKET BY SEGMENT 9, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 26. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 27. 3D PRINTED DRUGS MARKET BY SEGMENT 10, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 28. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 29. 3D PRINTED DRUGS MARKET BY SEGMENT 11, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 30. 3D PRINTED DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 31. U.S. 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 32. U.S. 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 33. U.S. 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 34. CANADA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 35. CANADA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 36. CANADA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 37. UK 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 38. UK 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 39. UK 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 40. GERMANY 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 41. GERMANY 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 42. GERMANY 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 43. ROE 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 44. ROE 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 45. ROE 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 46. CHINA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 47. CHINA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 48. CHINA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 49. INDIA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 50. INDIA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 51. INDIA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 52. JAPAN 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 53. JAPAN 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 54. JAPAN 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 55. ROAPAC 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 56. ROAPAC 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 57. ROAPAC 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 E 2015-2025 (USD MILLION/BILLION)
TABLE 58. BRAZIL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 59. BRAZIL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 60. BRAZIL 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 61. MEXICO 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 62. MEXICO 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT1 2015-2025 (USD MILLION/BILLION)
TABLE 63. MEXICO 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 64. ROLA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 65. ROLA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 66. ROLA 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 67. ROW 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 68. ROW 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 69. ROW 3D PRINTED DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の3Dプリント薬剤市場規模・予測2017-2025]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆